Allopurinol inhibits the metabolism of mercaptopurine which potentiates the affect of azathioprine and increases the risk of myelosuppression. The risk of myelosuppression is increased if there is concurrent use of other drugs that can cause a suppression of bone marrow.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.